Importer of Controlled Substances; Notice of Registration; Rhodes Technologies, 35057-35058 [2012-14163]
Download as PDF
<![CDATA[
35057
Federal Register / Vol. 77, No. 113 / Tuesday, June 12, 2012 / Notices
Drug
Schedule
srobinson on DSK4SPTVN1PROD with NOTICES
Etorphine HCI (9059) ..................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Diphenoxylate (9170) ..................................................................................................................................................................................
Benzoylecgonine (9180) ..............................................................................................................................................................................
Ethylmorphine (9190) ..................................................................................................................................................................................
Hydrocodone (9193) ....................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Isomethadone (9226) ..................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Meperidine intermediate-B (9233) ...............................................................................................................................................................
Metazocine (9240) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Methadone intermediate (9254) ..................................................................................................................................................................
Metopon (9260) ...........................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) (9273) ..............................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Dihydroetorphine (9334) ..............................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Oxymorphone (9652) ...................................................................................................................................................................................
Noroxymorphone (9668) ..............................................................................................................................................................................
Phenazocine (9715) ....................................................................................................................................................................................
Piminodine (9730) .......................................................................................................................................................................................
Racemethorphan (9732) ..............................................................................................................................................................................
Racemorphan (9733) ...................................................................................................................................................................................
Alfentanil (9737) ..........................................................................................................................................................................................
Remifentanil (9739) .....................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
Carfentanil (9743) ........................................................................................................................................................................................
Tapentadol (9780) .......................................................................................................................................................................................
Bezitramide (9800) ......................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Lipomed, Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971.
DEA has investigated Lipomed, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
VerDate Mar<15>2010
22:42 Jun 11, 2012
Jkt 226001
Dated: June 4, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–14162 Filed 6–11–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Rhodes
Technologies
By Notice dated April 17, 2012, and
published in the Federal Register on
April 26, 2012, 77 FR 24984, Rhodes
Technologies, 498 Washington Street,
Coventry, Rhode Island 02816, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances:
Drug
Schedule
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
II
II
The company plans to import the
listed controlled substances in order to
PO 00000
Frm 00125
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
bulk manufacture controlled substances
in Active Pharmaceutical Ingredient
(API) form.
The company distributes the
manufactured APIs in bulk form to its
customers.
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR
3417(2007)
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a) and determined
that the registration of Rhodes
Technologies to import the basic classes
of controlled substances is consistent
with the public interest, and with
United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Rhodes Technologies to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
E:\FR\FM\12JNN1.SGM
12JNN1
35058
Federal Register / Vol. 77, No. 113 / Tuesday, June 12, 2012 / Notices
importer of the basic classes of
controlled substances listed.
DEPARTMENT OF LABOR
Office of the Secretary
Dated: June 5, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Pilot
Surveys of Employee Voice in the Coal
Mining Industry
[FR Doc. 2012–14163 Filed 6–11–12; 8:45 am]
BILLING CODE 4410–09–P
ACTION:
Notice.
The Department of Labor
(DOL) is submitting the Mine Safety and
Health Administration (MSHA)
sponsored new information collection
request (ICR) titled, ‘‘Pilot Surveys of
Employee Voice in the Coal Mining
Industry,’’ to the Office of Management
and Budget (OMB) for review and
approval for use in accordance with the
Paperwork Reduction Act (PRA) of 1995
(44 U.S.C. 3501 et seq.).
DATES: Submit comments on or before
July 12, 2012.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained from the RegInfo.gov
Web site, https://www.reginfo.gov/
public/do/PRAMain, on the day
following publication of this notice or
by contacting Michel Smyth by
telephone at 202–693–4129 (this is not
a toll-free number) or sending an email
to DOL_PRA_PUBLIC@dol.gov.
Submit comments about this request
to the Office of Information and
Regulatory Affairs, Attn: OMB Desk
Officer for DOL–MSHA, Office of
Management and Budget, Room 10235,
New Executive Office Building,
Washington, DC 20503, Telephone:
202–395–6929/Fax: 202–395–6881
(these are not toll-free numbers), email:
OIRA_submission@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Michel Smyth by telephone at 202–693–
4129 (this is not a toll-free number) or
by email at DOL_PRA_PUBLIC@dol.gov.
SUPPLEMENTARY INFORMATION: The DOL
seeks OMB approval to conduct an
information collection as part of a pilot
study to determine how to measure
workers’ voice in mining workplaces
under the jurisdiction of the MSHA. The
DOL working definition for voice in the
workplace is workers’ ability to access
information on their rights in the
workplace, their understanding of those
rights, and their ability to exercise these
rights without fear of discrimination or
retaliation. Voice in the workplace is a
key outcome goal for the Secretary of
Labor and part of her vision of good jobs
for everyone. A separate concurrent
effort will measure workers’ voice in
SUMMARY:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application;
Apertus Pharmaceuticals, LLC
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 27, 2012,
Apertus Pharmaceuticals, LLC, 331
Consort Drive, St Louis, Missouri 63011,
made application to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Schedule
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
II
II
II
II
srobinson on DSK4SPTVN1PROD with NOTICES
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
which will be distributed to their
customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than August 13, 2012.
Dated: June 4, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–14165 Filed 6–11–12; 8:45 am]
BILLING CODE 4410–09–P
VerDate Mar<15>2010
22:42 Jun 11, 2012
Jkt 226001
PO 00000
Frm 00126
Fmt 4703
Sfmt 4703
workplaces under the jurisdiction of the
Wage and Hour Division and
Occupational Safety and Health
Administration. Measuring voice among
miners, however, poses unique data
collection challenges, including
implementing a survey in a setting that
feels non-threatening to mine workers,
and asking questions in a format that
reflects mining community cultures and
practices. The DOL seeks to perform a
pilot study to investigate the efficacy of
different data collection methods and to
develop a survey instrument that is
appropriate for the mining community.
The primary research question is what
measures of voice and perceived noncompliance, combined with what modes
of data collection, could be best used to
track MSHA’s worker-protection
outreach activity? This ICR covers a set
two or three small-scale pilot data
collections. Data collection for this
effort will employ two or three
strategies: (1) Submission of paper
questionnaires to be filled out by
individual mine workers during offsite
mining-related training sessions, (2)
recruitment of miners by using radio
and paper advertisements, and (3) a
mail or phone survey. The DOL is
currently assessing the feasibility of
each method prior to implementation.
For example, implementation of a
phone or mail survey will depend on
the availability of a valid list of miners.
A maximum of 125 respondents will be
surveyed under each collection mode
for 375 maximum respondents for the
overall effort.
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless it is
approved by the OMB under the PRA
and displays a currently valid OMB
Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information if the
collection of information does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6. For
additional information, see the related
notice published in the Federal Register
on January 19, 2012 (77 FR 2760).
Interested parties are encouraged to
send comments to the OMB, Office of
Information and Regulatory Affairs at
the address shown in the ADDRESSES
section within 30 days of publication of
this notice in the Federal Register. In
order to help ensure appropriate
consideration, comments should
reference OMB ICR Reference Number
201205–1219–001. The OMB is
E:\FR\FM\12JNN1.SGM
12JNN1
]]>Agencies
[Federal Register Volume 77, Number 113 (Tuesday, June 12, 2012)]
[Notices]
[Pages 35057-35058]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-14163]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration; Rhodes
Technologies
By Notice dated April 17, 2012, and published in the Federal
Register on April 26, 2012, 77 FR 24984, Rhodes Technologies, 498
Washington Street, Coventry, Rhode Island 02816, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as an importer of the basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
order to bulk manufacture controlled substances in Active
Pharmaceutical Ingredient (API) form.
The company distributes the manufactured APIs in bulk form to its
customers.
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417(2007)
DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and
determined that the registration of Rhodes Technologies to import the
basic classes of controlled substances is consistent with the public
interest, and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971. DEA has
investigated Rhodes Technologies to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an
[[Page 35058]]
importer of the basic classes of controlled substances listed.
Dated: June 5, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-14163 Filed 6-11-12; 8:45 am]
BILLING CODE 4410-09-P
